Fulvestrant Plus Abemaciclib in Women With Advanced Low Grade Serous Carcinoma
Clinical trial NCT03531645 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03531645
- Sponsor
- M.D. Anderson Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-13
- Primary completion
- 2027-09-30
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.